Mark Peterson

EHang is bypassing traditional aviation treaties to launch pilotless eVTOLs in Vietnam. Will municipal sandboxes fast-track Southeast Asia's aerial revolution?

Institutional investors and GCC healthcare giants are treating the global women's health gap not as a niche, but as a $1 trillion macroeconomic catalyst.

Opus's appointment of Mark Kunkel signals a strategic shift from merchant builder to institutional fund manager amid commercial real estate's capital squeeze.

Fisher House and corporate giants deploy $1 million in micro-grants, bridging tuition gaps for military families via strategic supply-chain philanthropy.

Red Spruce Capital’s sponsorship of the Drexel Economic Forum highlights how mid-sized RIAs leverage academic prestige to capture elite market mindshare.

A new Aerotek survey reveals industrial workers are trading starting wages for upskilling, while employer ghosting outpaces AI fears in the talent war.

By solving a decades-old food safety crisis with patented cold-growth technology, RäFoods has transformed a high-risk grocery staple into a retail powerhouse.

Amid a severe shortage of medical dosimetrists, Radformation’s model-free VMAT automation could redefine the economics and workflow of radiation oncology.

As Bacardi moves its flagship festival to Dehradun, the strategic shift reveals how global alcohol brands are using experiential IPs to bypass strict ad laws.

With coal fly ash vanishing, a Connecticut climate tech firm is turning municipal glass waste into low-carbon concrete for major rail infrastructure projects.

Goddess Maintenance Co.'s BeautyMatter Award nomination signals a lucrative shift from reactive bond repair to immediate biotech-driven hair longevity.

A $2.5M Canadian class action settlement exposes the hidden costs of a global auto parts cartel, revealing how supply chain oligopolies inflate vehicle prices.

The Genome Partnership's latest awards aren't just accolades; they're a roadmap. See how ten emerging scientists are leading the charge into AI-driven healthcare.

A massive infrastructure spend isn't just about keeping the lights on. It's a strategic move into green energy, Indigenous partnership, and future market control.

At ECOC 2026, MACOM unveils the foundational tech for 3.2T optics and PCIe 7.0, signaling a critical move to solve the data bottlenecks that threaten to throttle AI.

Struggling ed-tech firm Jinxin Technology is betting its future on AI-generated micro-dramas with a complex new deal. Is it a visionary leap or a desperate gamble?

With impressive Phase 2 data, Revelyx Bio's ready-to-use recombinant toxin YY003 signals a major technological and practical shift for the aesthetics industry.

A new partnership between Grantd and Collective Liquidity aims to unlock billions in illiquid stock, transforming how advisors and employees manage pre-IPO wealth.

Karimah Es Sabar, a titan who has raised over $1.5B in bioscience, joins Linearis Ventures. This move signals a major bet on a new model for health-tech investing.

A veteran team with a pharma exit under its belt just raised $10.8M to aim AI at a notoriously tough drug target. Here’s why investors are buying the signal.